/viestories/media/media_files/2025/02/14/aBvSzi2CpQcxyvXzKtOK.png)
Caplin Point Share Price Target
Caplin Point Laboratories Ltd is a listed company with rapidly growing stock prices. Due to high demand, the stock has reached higher valuations in a short time.
The company has consistently met its past targets, increasing the likelihood of achieving the Caplin Point Share Price Target for 2025.
Table of Contents
Caplin Point Share Price Target 2025:-
Caplin Point Share Price Target 2025 – The stock is expected to range between ₹2027.65 and ₹2111.22 throughout the year. With strong growth momentum and increasing demand, Caplin Point Laboratories remains a promising investment. Stay updated on market trends for informed decisions.
Months | Target Prices |
January | 2027.65 |
February | 2029.54 |
March | 2037.54 |
April | 2042.65 |
May | 2051.23 |
June | 2058.95 |
July | 2067.55 |
August | 2078.41 |
September | 2089.56 |
October | 2095.61 |
November | 2102.32 |
December | 2111.22 |
Know more about the best traders in India.
Caplin Point Share Price Target 2026:-
Caplin Point Share Price Target 2026 – The stock is expected to range between ₹2125.62 and ₹2195.48 throughout the year. With steady growth and strong market performance, Caplin Point Laboratories continues to be a key player in the pharmaceutical sector. Stay updated on price trends for better investment decisions.
Months | Target Prices |
January | 2125.62 |
February | 2128.74 |
March | 2134.56 |
April | 2145.26 |
May | 2158.44 |
June | 2163.02 |
July | 2174.15 |
August | 2180.02 |
September | 2186.45 |
October | 2189.47 |
November | 2192.33 |
December | 2195.48 |
Caplin Point Share Price Target 2027:-
Caplin Point Share Price Target 2027 – The stock is expected to trade between ₹2198.74 and ₹2268.47 throughout the year. With continued growth in the pharmaceutical sector, Caplin Point Laboratories remains a strong investment option. Stay updated on market trends for informed decisions.
Months | Target Prices |
January | 2198.74 |
February | 2199.55 |
March | 2215.26 |
April | 2227.48 |
May | 2231.02 |
June | 2237.56 |
July | 2245.61 |
August | 2248.23 |
September | 2253.62 |
October | 2261.20 |
November | 2265.78 |
December | 2268.47 |
Caplin Point Share Price Target 2028:-
Caplin Point Share Price Target 2028 – The stock is expected to trade between ₹2274.15 and ₹2334.15 throughout the year. With steady growth in the pharmaceutical sector, Caplin Point Laboratories continues to attract investors. Stay updated on market trends for informed investment decisions.
Months | Target Prices |
January | 2274.15 |
February | 2278.95 |
March | 2280.32 |
April | 2284.62 |
May | 2288.32 |
June | 2293.54 |
July | 2297.51 |
August | 2302.12 |
September | 2315.26 |
October | 2318.47 |
November | 2326.24 |
December | 2334.15 |
Caplin Point Share Price Target 2029:-
Caplin Point Share Price Target 2029 – The stock is expected to range between ₹2338.55 and ₹2381.22 throughout the year. With consistent growth in the pharmaceutical sector, Caplin Point Laboratories remains a strong investment option. Stay updated on market trends for better investment decisions.
Months | Target Prices |
January | 2338.55 |
February | 2341.20 |
March | 2346.78 |
April | 2348.59 |
May | 2352.02 |
June | 2356.48 |
July | 2358.61 |
August | 2362.23 |
September | 2368.75 |
October | 2375.48 |
November | 2379.85 |
December | 2381.22 |
Caplin Point Share Price Target 2030:-
Caplin Point Share Price Target 2030 – The stock is expected to trade between ₹2382.54 and ₹2435.16. With steady growth in the pharmaceutical sector, Caplin Point Laboratories continues to attract investor interest. Stay updated on market trends for informed investment decisions.
Months | Target Prices |
January | 2382.54 |
February | 2385.61 |
March | 2388.75 |
April | 2389.23 |
May | 2393.47 |
June | 2397.56 |
July | 2411.20 |
August | 2415.63 |
September | 2418.75 |
October | 2420.23 |
November | 2428.56 |
December | 2435.16 |
Caplin Point Laboratories Ltd Shareholding Pattern:-
Shareholders | Share Percentage |
Promoters | 70.56 percent |
Retail and others | 24.57 percent |
FII | 3.37 percent |
Mutual Funds | 1.32 percent |
DII | 0.17 percent |
Conclusion -
Caplin Point Laboratories Ltd is a listed company with rapidly rising stock prices. Strong demand has driven significant growth in a short period, helping the company achieve its past targets. With its current momentum, Caplin Point is on track to meet its 2025 share price targets with ease.
FAQs
Disclaimer:
- The information is based on our understanding of the stock's historical performance.
- Stock market predictions are unpredictable and can change, so expert advice is strongly recommended before investing.
- The values provided are based on predictions and may not be accurate, we recommend verifying the information with other sources.
- For further inquiries about the stock market, please contact us via email.